E. Gerald Kay

2022

In 2022, E. Gerald Kay earned a total compensation of $286.4K as Executive Chairman and President at Integrated Biopharma.

Compensation breakdown

Option Awards$33,651
Salary$215,693
Other$37,036
Total$286,380

Kay received $215.7K in salary, accounting for 75% of the total pay in 2022.

Kay also received $33.7K in option awards and $37K in other compensation.

Rankings

In 2022, E. Gerald Kay's compensation ranked 5,139th out of 5,756 executives tracked by ExecPay. In other words, Kay earned more than 10.7% of executives.

ClassificationRankingPercentile
All
5,139
out of 5,756
11th
Division
Manufacturing
2,822
out of 3,133
10th
Major group
Chemicals And Allied Products
1,311
out of 1,419
8th
Industry group
Drugs
1,232
out of 1,320
7th
Industry
Pharmaceutical Preparations
899
out of 966
7th
Source: SEC filing on October 27, 2023.

Kay's colleagues

We found four more compensation records of executives who worked with E. Gerald Kay at Integrated Biopharma in 2022.

2022

Dina Masi

Integrated Biopharma

Chief Financial Officer

2022

EGerald Kay

Integrated Biopharma

Chairman

2022

Riva Sheppard

Integrated Biopharma

Chief Executive Officer

2022

Christina Kay

Integrated Biopharma

Chief Executive Officer

News

You may also like